Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxa11
|
ENSMUSG00000038210.9 | homeobox A11 |
Hoxc12
|
ENSMUSG00000050328.2 | homeobox C12 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_52245738_52245923 | Hoxa11 | 20 | 0.611438 | 0.60 | 1.3e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_14351950_14353283 | 59.40 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr9_29318648_29319159 | 21.74 |
Ntm |
neurotrimin |
92833 |
0.1 |
chr7_92688003_92688166 | 20.96 |
Pcf11 |
PCF11 cleavage and polyadenylation factor subunit |
18150 |
0.11 |
chr6_52200956_52201123 | 20.03 |
Hoxaas3 |
Hoxa cluster antisense RNA 3 |
85 |
0.88 |
chr1_186964588_186964743 | 19.46 |
D1Pas1 |
DNA segment, Chr 1, Pasteur Institute 1 |
2751 |
0.18 |
chr17_87628266_87628422 | 18.90 |
Epcam |
epithelial cell adhesion molecule |
7635 |
0.2 |
chr15_103014087_103015222 | 18.07 |
Mir615 |
microRNA 615 |
256 |
0.74 |
chr8_96868416_96868585 | 17.57 |
Gm24132 |
predicted gene, 24132 |
212371 |
0.02 |
chr6_52213227_52213582 | 17.35 |
Gm28308 |
predicted gene 28308 |
65 |
0.48 |
chr11_96303094_96303989 | 17.20 |
Hoxb5 |
homeobox B5 |
29 |
0.92 |
chr14_74915830_74916012 | 17.09 |
Gm10847 |
predicted gene 10847 |
10524 |
0.2 |
chr9_15964185_15964748 | 16.23 |
Fat3 |
FAT atypical cadherin 3 |
6644 |
0.29 |
chr11_108241078_108241308 | 16.18 |
Gm11655 |
predicted gene 11655 |
59343 |
0.12 |
chr1_105784247_105784562 | 15.73 |
Tnfrsf11a |
tumor necrosis factor receptor superfamily, member 11a, NFKB activator |
3654 |
0.21 |
chr6_6433168_6433443 | 15.68 |
Gm20685 |
predicted gene 20685 |
49717 |
0.12 |
chr2_59600114_59600421 | 15.64 |
Tanc1 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 |
11775 |
0.23 |
chr12_108110779_108110970 | 15.59 |
Setd3 |
SET domain containing 3 |
4073 |
0.29 |
chr4_5494714_5495053 | 15.52 |
Gm11782 |
predicted gene 11782 |
56340 |
0.15 |
chr2_171735246_171735530 | 15.06 |
1700028P15Rik |
RIKEN cDNA 1700028P15 gene |
226743 |
0.02 |
chr7_142593653_142594017 | 15.05 |
Gm33148 |
predicted gene, 33148 |
2091 |
0.19 |
chr8_53171807_53171969 | 14.99 |
Gm23666 |
predicted gene, 23666 |
165480 |
0.04 |
chr2_15526355_15526523 | 14.94 |
Malrd1 |
MAM and LDL receptor class A domain containing 1 |
40 |
0.98 |
chr2_153249814_153250196 | 14.90 |
Pofut1 |
protein O-fucosyltransferase 1 |
7477 |
0.14 |
chr6_52204413_52204627 | 14.84 |
Hoxa5 |
homeobox A5 |
67 |
0.89 |
chrX_167483924_167484085 | 14.84 |
Gm6744 |
predicted gene 6744 |
37473 |
0.18 |
chr1_82766345_82766504 | 14.71 |
Tm4sf20 |
transmembrane 4 L six family member 20 |
2037 |
0.17 |
chr2_74711743_74712019 | 14.65 |
Hoxd3 |
homeobox D3 |
46 |
0.39 |
chr7_141276747_141276904 | 14.60 |
Cdhr5 |
cadherin-related family member 5 |
39 |
0.93 |
chr4_35052158_35052356 | 14.59 |
Gm12364 |
predicted gene 12364 |
90037 |
0.06 |
chr13_74099323_74099504 | 13.92 |
Slc9a3 |
solute carrier family 9 (sodium/hydrogen exchanger), member 3 |
22044 |
0.14 |
chr19_24848418_24848569 | 13.82 |
Gm50342 |
predicted gene, 50342 |
7703 |
0.16 |
chr1_191071780_191072059 | 13.07 |
Gm38188 |
predicted gene, 38188 |
6761 |
0.1 |
chr9_60307520_60307692 | 13.01 |
2010001M07Rik |
RIKEN cDNA 2010001M07 gene |
26536 |
0.21 |
chr7_112321852_112322152 | 13.00 |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
5973 |
0.3 |
chr10_18995546_18995706 | 13.00 |
Tnfaip3 |
tumor necrosis factor, alpha-induced protein 3 |
13219 |
0.21 |
chr10_44490967_44491315 | 12.99 |
Prdm1 |
PR domain containing 1, with ZNF domain |
32393 |
0.15 |
chr18_6745001_6745152 | 12.99 |
Rab18 |
RAB18, member RAS oncogene family |
11171 |
0.18 |
chr4_100435665_100436137 | 12.95 |
Ube2u |
ubiquitin-conjugating enzyme E2U (putative) |
42948 |
0.16 |
chr2_91452618_91452961 | 12.95 |
Lrp4 |
low density lipoprotein receptor-related protein 4 |
4722 |
0.17 |
chr6_99328705_99329043 | 12.90 |
Gm20705 |
predicted gene 20705 |
59625 |
0.13 |
chr15_93711208_93711537 | 12.89 |
Gm41386 |
predicted gene, 41386 |
1397 |
0.44 |
chr4_11103092_11103288 | 12.87 |
Gm11827 |
predicted gene 11827 |
19615 |
0.12 |
chr19_11018008_11018162 | 12.87 |
Ms4a18 |
membrane-spanning 4-domains, subfamily A, member 18 |
54 |
0.95 |
chr5_113919233_113919389 | 12.81 |
Gm22056 |
predicted gene, 22056 |
9493 |
0.11 |
chr4_80950257_80950475 | 12.81 |
Gm27452 |
predicted gene, 27452 |
17078 |
0.24 |
chr6_148373522_148373758 | 12.72 |
Gm44021 |
predicted gene, 44021 |
8984 |
0.15 |
chr5_100568224_100568403 | 12.67 |
Plac8 |
placenta-specific 8 |
3879 |
0.16 |
chr14_106154967_106155130 | 12.66 |
Trim52 |
tripartite motif-containing 52 |
48849 |
0.11 |
chr6_66382723_66382897 | 12.61 |
Gm44281 |
predicted gene, 44281 |
15906 |
0.17 |
chr1_82991731_82991888 | 12.53 |
Gm47959 |
predicted gene, 47959 |
8739 |
0.09 |
chr5_147315601_147315782 | 12.26 |
Urad |
ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5) decarboxylase |
6749 |
0.11 |
chr2_5599796_5600119 | 12.25 |
Gm13216 |
predicted gene 13216 |
3614 |
0.33 |
chr17_47634147_47634313 | 12.19 |
Usp49 |
ubiquitin specific peptidase 49 |
3540 |
0.12 |
chr3_38579892_38580068 | 12.12 |
Gm7824 |
predicted gene 7824 |
21312 |
0.16 |
chr3_104227319_104227590 | 12.11 |
Magi3 |
membrane associated guanylate kinase, WW and PDZ domain containing 3 |
7080 |
0.13 |
chr14_20208427_20208821 | 12.09 |
Gm48395 |
predicted gene, 48395 |
6878 |
0.13 |
chr15_99865576_99865855 | 12.02 |
Lima1 |
LIM domain and actin binding 1 |
8956 |
0.08 |
chr17_31322632_31322810 | 11.91 |
Slc37a1 |
solute carrier family 37 (glycerol-3-phosphate transporter), member 1 |
467 |
0.76 |
chr6_87219656_87219938 | 11.89 |
Gm44417 |
predicted gene, 44417 |
35811 |
0.1 |
chr5_5284129_5284282 | 11.54 |
Cdk14 |
cyclin-dependent kinase 14 |
17902 |
0.17 |
chr17_87638274_87638425 | 11.51 |
Epcam |
epithelial cell adhesion molecule |
1667 |
0.38 |
chr3_144849567_144849863 | 11.49 |
Clca3b |
chloride channel accessory 3B |
358 |
0.79 |
chr5_48679826_48680024 | 11.48 |
Gm19031 |
predicted gene, 19031 |
14020 |
0.16 |
chr12_83708566_83708720 | 11.44 |
Psen1 |
presenilin 1 |
15996 |
0.12 |
chr13_60308031_60308773 | 11.44 |
Gm24999 |
predicted gene, 24999 |
14730 |
0.18 |
chr4_7171733_7171931 | 11.31 |
Gm11804 |
predicted gene 11804 |
132318 |
0.05 |
chr11_87680890_87681041 | 11.29 |
Gm25968 |
predicted gene, 25968 |
13616 |
0.11 |
chr10_27595792_27595948 | 11.28 |
Gm36962 |
predicted gene, 36962 |
19458 |
0.2 |
chr1_125550003_125550172 | 11.27 |
Slc35f5 |
solute carrier family 35, member F5 |
10508 |
0.27 |
chr10_42723467_42723801 | 11.20 |
Gm15200 |
predicted gene 15200 |
25116 |
0.14 |
chr17_77200158_77200549 | 11.20 |
Rpsa-ps8 |
ribosomal protein SA, pseudogene 8 |
162857 |
0.04 |
chr4_136853085_136853269 | 11.16 |
Ephb2 |
Eph receptor B2 |
17189 |
0.15 |
chr11_83913875_83914336 | 11.13 |
Ddx52 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 52 |
27957 |
0.14 |
chr1_42388111_42388356 | 11.06 |
Gm28140 |
predicted gene 28140 |
32296 |
0.2 |
chr2_160332750_160333092 | 10.99 |
Gm826 |
predicted gene 826 |
1241 |
0.56 |
chr7_84022530_84022842 | 10.82 |
Cemip |
cell migration inducing protein, hyaluronan binding |
46611 |
0.13 |
chr18_21106064_21106215 | 10.67 |
Gm6378 |
predicted pseudogene 6378 |
29030 |
0.18 |
chr6_72465653_72465804 | 10.66 |
Mat2a |
methionine adenosyltransferase II, alpha |
26170 |
0.1 |
chr8_115826214_115826384 | 10.51 |
Maf |
avian musculoaponeurotic fibrosarcoma oncogene homolog |
118505 |
0.06 |
chr7_123097743_123098471 | 10.47 |
Tnrc6a |
trinucleotide repeat containing 6a |
25778 |
0.17 |
chr2_169621269_169621488 | 10.43 |
Gm34294 |
predicted gene, 34294 |
6940 |
0.21 |
chr6_119642744_119642914 | 10.30 |
Erc1 |
ELKS/RAB6-interacting/CAST family member 1 |
20724 |
0.22 |
chr5_46083575_46083759 | 10.28 |
4930405L22Rik |
RIKEN cDNA 4930405L22 gene |
151258 |
0.04 |
chr15_81033039_81033202 | 10.26 |
Gm25131 |
predicted gene, 25131 |
6523 |
0.14 |
chr1_42496369_42496561 | 10.19 |
Gm37047 |
predicted gene, 37047 |
4652 |
0.3 |
chr4_106799129_106799308 | 10.17 |
Acot11 |
acyl-CoA thioesterase 11 |
572 |
0.72 |
chr2_74705947_74706125 | 10.13 |
Hoxd8 |
homeobox D8 |
884 |
0.25 |
chr2_122441473_122441624 | 10.12 |
Slc28a2 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 2 |
785 |
0.55 |
chr4_45640873_45641024 | 10.09 |
Gm12408 |
predicted gene 12408 |
420 |
0.84 |
chr11_58953843_58955382 | 10.07 |
H2aw |
H2A.W histone |
73 |
0.33 |
chr4_11732297_11732618 | 10.06 |
Cdh17 |
cadherin 17 |
25690 |
0.16 |
chr13_58364524_58364690 | 10.01 |
Kif27 |
kinesin family member 27 |
5485 |
0.13 |
chr14_8362697_8362848 | 10.00 |
2610318M16Rik |
RIKEN cDNA 2610318M16 gene |
4668 |
0.2 |
chr13_54676322_54676482 | 9.99 |
Rnf44 |
ring finger protein 44 |
7670 |
0.13 |
chr5_95864834_95864992 | 9.77 |
Gm25937 |
predicted gene, 25937 |
2421 |
0.24 |
chr17_12801980_12802361 | 9.64 |
Gm49958 |
predicted gene, 49958 |
1375 |
0.25 |
chr15_102959985_102960190 | 9.63 |
Hoxc11 |
homeobox C11 |
5660 |
0.08 |
chr6_94719015_94719242 | 9.62 |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
18970 |
0.2 |
chr7_55910995_55911146 | 9.58 |
Cyfip1 |
cytoplasmic FMR1 interacting protein 1 |
2698 |
0.18 |
chr4_117630417_117630617 | 9.57 |
Eri3 |
exoribonuclease 3 |
6821 |
0.17 |
chr15_96735673_96735829 | 9.52 |
Gm8888 |
predicted gene 8888 |
31327 |
0.15 |
chr12_92193299_92193551 | 9.51 |
Gm6841 |
predicted gene 6841 |
25952 |
0.2 |
chr1_185431858_185432017 | 9.45 |
AC131980.1 |
solute carrier family 30, member 10 (Slc30a10) pseudogene |
76 |
0.95 |
chr10_20621771_20622008 | 9.44 |
Gm17230 |
predicted gene 17230 |
3746 |
0.3 |
chr19_47104988_47105153 | 9.43 |
Pdcd11 |
programmed cell death 11 |
14302 |
0.09 |
chr19_5559890_5560068 | 9.43 |
1810058N15Rik |
RIKEN cDNA 1810058N15 gene |
281 |
0.63 |
chr8_120492319_120492599 | 9.37 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
4012 |
0.17 |
chr10_19105296_19105472 | 9.34 |
Gm48545 |
predicted gene, 48545 |
3789 |
0.17 |
chr10_17522116_17522313 | 9.34 |
Gm47769 |
predicted gene, 47769 |
1606 |
0.36 |
chr7_65469957_65470108 | 9.30 |
Gm44792 |
predicted gene 44792 |
11189 |
0.21 |
chrX_21586040_21586450 | 9.27 |
Gm14558 |
predicted gene 14558 |
32265 |
0.17 |
chr1_54600425_54600771 | 9.26 |
Gm19637 |
predicted gene, 19637 |
33895 |
0.14 |
chr19_29475251_29475601 | 9.25 |
A930007I19Rik |
RIKEN cDNA A930007I19 gene |
45544 |
0.11 |
chr8_8556281_8556436 | 9.23 |
Gm31463 |
predicted gene, 31463 |
20164 |
0.14 |
chr11_70070138_70070289 | 9.21 |
Asgr1 |
asialoglycoprotein receptor 1 |
14332 |
0.08 |
chr3_83266059_83266378 | 9.18 |
Gm10710 |
predicted gene 10710 |
136972 |
0.04 |
chr17_54685745_54685939 | 9.18 |
Gm26291 |
predicted gene, 26291 |
33906 |
0.22 |
chr5_67931488_67931792 | 9.16 |
Gm5108 |
predicted gene 5108 |
10029 |
0.13 |
chr1_86479174_86479713 | 9.15 |
Rpl30-ps6 |
ribosomal protein L30, pseudogene 6 |
5784 |
0.15 |
chr5_64575874_64576255 | 9.14 |
Gm42566 |
predicted gene 42566 |
11245 |
0.12 |
chr2_157412634_157412785 | 9.13 |
Src |
Rous sarcoma oncogene |
5735 |
0.19 |
chr13_60226263_60226471 | 9.13 |
Gm5084 |
predicted gene 5084 |
14434 |
0.17 |
chr8_36073345_36073516 | 9.12 |
Prag1 |
PEAK1 related kinase activating pseudokinase 1 |
21398 |
0.17 |
chr9_92294257_92294443 | 9.12 |
Plscr2 |
phospholipid scramblase 2 |
3531 |
0.17 |
chr8_88723385_88723536 | 9.07 |
Gm17995 |
predicted gene, 17995 |
1852 |
0.29 |
chr4_44042479_44042779 | 9.06 |
Gne |
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
12668 |
0.13 |
chr11_44549989_44550247 | 9.04 |
Rnf145 |
ring finger protein 145 |
6713 |
0.19 |
chr18_47329586_47329952 | 9.04 |
Sema6a |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
3557 |
0.29 |
chr14_72172665_72172822 | 9.04 |
Gm49290 |
predicted gene, 49290 |
22953 |
0.23 |
chr15_64258115_64258266 | 9.00 |
Asap1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain1 |
49699 |
0.13 |
chr12_73883828_73884266 | 8.99 |
Gm15283 |
predicted gene 15283 |
14435 |
0.16 |
chr10_119206558_119206829 | 8.99 |
Cand1 |
cullin associated and neddylation disassociated 1 |
1516 |
0.41 |
chr18_72532259_72532570 | 8.97 |
Gm6995 |
predicted gene 6995 |
105306 |
0.08 |
chr9_99471385_99471672 | 8.96 |
Nme9 |
NME/NM23 family member 9 |
1107 |
0.5 |
chr8_117388489_117388730 | 8.95 |
Cmip |
c-Maf inducing protein |
34807 |
0.17 |
chr12_8865143_8865294 | 8.94 |
9930038B18Rik |
RIKEN cDNA 9930038B18 gene |
12164 |
0.18 |
chr9_101053408_101053575 | 8.93 |
Gm3096 |
predicted gene 3096 |
51 |
0.96 |
chr19_40995535_40995701 | 8.93 |
Blnk |
B cell linker |
1083 |
0.54 |
chr3_49908961_49909291 | 8.93 |
Gm37854 |
predicted gene, 37854 |
92846 |
0.08 |
chr11_79113006_79113168 | 8.93 |
Ksr1 |
kinase suppressor of ras 1 |
33320 |
0.16 |
chr7_43634054_43634309 | 8.92 |
Ceacam18 |
carcinoembryonic antigen-related cell adhesion molecule 18 |
526 |
0.59 |
chr1_61751137_61751288 | 8.80 |
Gm38278 |
predicted gene, 38278 |
48685 |
0.12 |
chr4_118127727_118128030 | 8.79 |
St3gal3 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 3 |
7004 |
0.17 |
chr1_9023521_9023672 | 8.76 |
Gm7493 |
predicted gene 7493 |
59975 |
0.12 |
chr4_95771650_95771804 | 8.75 |
Fggy |
FGGY carbohydrate kinase domain containing |
2218 |
0.43 |
chr2_140896812_140896972 | 8.73 |
Calr-ps |
calreticulin, pseudogene |
59357 |
0.15 |
chr14_60702854_60703018 | 8.71 |
Spata13 |
spermatogenesis associated 13 |
17 |
0.98 |
chr11_19424471_19424650 | 8.71 |
Gm12026 |
predicted gene 12026 |
40875 |
0.18 |
chr6_67437897_67438168 | 8.70 |
Gm44083 |
predicted gene, 44083 |
19981 |
0.12 |
chr10_125171349_125171500 | 8.68 |
Slc16a7 |
solute carrier family 16 (monocarboxylic acid transporters), member 7 |
137392 |
0.05 |
chr18_51758490_51758660 | 8.66 |
Gm4950 |
predicted pseudogene 4950 |
107306 |
0.07 |
chr1_105088844_105089211 | 8.64 |
Gm29012 |
predicted gene 29012 |
27427 |
0.23 |
chr15_70600886_70601046 | 8.63 |
Gm18155 |
predicted gene, 18155 |
157087 |
0.04 |
chr10_99114195_99114523 | 8.63 |
Galnt4 |
polypeptide N-acetylgalactosaminyltransferase 4 |
6200 |
0.14 |
chr6_94710006_94710162 | 8.61 |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
9926 |
0.23 |
chr18_20958798_20958967 | 8.60 |
Rnf125 |
ring finger protein 125 |
2590 |
0.3 |
chr1_55174136_55174492 | 8.57 |
Gm6822 |
predicted pseudogene 6822 |
13261 |
0.12 |
chr4_115795467_115795652 | 8.56 |
Atpaf1 |
ATP synthase mitochondrial F1 complex assembly factor 1 |
155 |
0.93 |
chr9_92229905_92230222 | 8.52 |
Plscr1 |
phospholipid scramblase 1 |
19687 |
0.15 |
chr18_53846422_53846602 | 8.50 |
Csnk1g3 |
casein kinase 1, gamma 3 |
15610 |
0.27 |
chr2_11399207_11399417 | 8.46 |
8030442B05Rik |
RIKEN cDNA 8030442B05 gene |
811 |
0.45 |
chr4_71356336_71356699 | 8.46 |
Rps18-ps1 |
ribosomal protein S18, pseudogene 1 |
14679 |
0.27 |
chr10_20203422_20203752 | 8.46 |
4930405J17Rik |
RIKEN cDNA 4930405J17 gene |
1749 |
0.3 |
chr14_76817069_76817629 | 8.45 |
Gm48968 |
predicted gene, 48968 |
15472 |
0.18 |
chr7_70796096_70796247 | 8.43 |
Gm24880 |
predicted gene, 24880 |
43755 |
0.16 |
chr7_66601071_66601305 | 8.40 |
Gm44610 |
predicted gene 44610 |
17960 |
0.15 |
chr6_28389116_28389345 | 8.37 |
Zfp800 |
zinc finger protein 800 |
8775 |
0.14 |
chr10_116884549_116884846 | 8.35 |
Myrfl |
myelin regulatory factor-like |
12222 |
0.16 |
chr11_62826279_62826430 | 8.34 |
Trim16 |
tripartite motif-containing 16 |
5885 |
0.13 |
chr4_94650048_94650199 | 8.32 |
Lrrc19 |
leucine rich repeat containing 19 |
7 |
0.97 |
chr6_18248492_18248868 | 8.32 |
Cftr |
cystic fibrosis transmembrane conductance regulator |
6544 |
0.2 |
chr7_72990908_72991250 | 8.31 |
Gm5335 |
predicted gene 5335 |
926 |
0.67 |
chr2_113401304_113401455 | 8.29 |
Fmn1 |
formin 1 |
920 |
0.54 |
chr1_94905103_94905254 | 8.28 |
4930440C22Rik |
RIKEN cDNA 4930440C22 gene |
107736 |
0.07 |
chr11_67031121_67031326 | 8.26 |
Tmem220 |
transmembrane protein 220 |
6069 |
0.14 |
chr10_117644446_117644647 | 8.26 |
Cpm |
carboxypeptidase M |
15046 |
0.12 |
chr5_113789227_113789902 | 8.25 |
Tmem119 |
transmembrane protein 119 |
10882 |
0.09 |
chr14_23132370_23132531 | 8.20 |
Gm10248 |
predicted gene 10248 |
37879 |
0.22 |
chr11_8584418_8584636 | 8.13 |
Tns3 |
tensin 3 |
5406 |
0.34 |
chr4_106623961_106624112 | 8.12 |
Ttc22 |
tetratricopeptide repeat domain 22 |
1604 |
0.26 |
chr2_60203863_60204022 | 8.08 |
Baz2b |
bromodomain adjacent to zinc finger domain, 2B |
5217 |
0.18 |
chr11_45838507_45838961 | 8.06 |
Gm22751 |
predicted gene, 22751 |
8955 |
0.14 |
chr13_102065327_102065524 | 8.04 |
Gm38133 |
predicted gene, 38133 |
50610 |
0.17 |
chr3_104244460_104244622 | 8.04 |
Magi3 |
membrane associated guanylate kinase, WW and PDZ domain containing 3 |
24167 |
0.11 |
chr17_73902189_73902648 | 8.02 |
Xdh |
xanthine dehydrogenase |
2011 |
0.31 |
chr9_71242241_71242392 | 7.96 |
Aldh1a2 |
aldehyde dehydrogenase family 1, subfamily A2 |
26527 |
0.17 |
chr6_12812173_12812477 | 7.95 |
Gm15529 |
predicted gene 15529 |
45072 |
0.15 |
chr15_102997941_102998298 | 7.94 |
Hoxc6 |
homeobox C6 |
138 |
0.9 |
chr15_103000513_103000885 | 7.88 |
Hoxc6 |
homeobox C6 |
170 |
0.88 |
chr16_88599937_88600275 | 7.86 |
Gm49688 |
predicted gene, 49688 |
8564 |
0.11 |
chr16_13276831_13277004 | 7.85 |
Mrtfb |
myocardin related transcription factor B |
11841 |
0.25 |
chr13_95836966_95837329 | 7.77 |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
54610 |
0.11 |
chr8_68719023_68719273 | 7.77 |
Csgalnact1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
15954 |
0.22 |
chr6_17990763_17990920 | 7.77 |
Wnt2 |
wingless-type MMTV integration site family, member 2 |
39744 |
0.14 |
chr15_81555021_81555197 | 7.76 |
1110025M09Rik |
RIKEN cDNA 1110025M09 gene |
29919 |
0.09 |
chr10_16978950_16979101 | 7.75 |
Gm20125 |
predicted gene, 20125 |
1877 |
0.48 |
chr1_39593976_39594137 | 7.74 |
Gm5100 |
predicted gene 5100 |
3949 |
0.15 |
chr9_120547138_120547289 | 7.71 |
Entpd3 |
ectonucleoside triphosphate diphosphohydrolase 3 |
7395 |
0.12 |
chr13_55374613_55374813 | 7.71 |
Rgs14 |
regulator of G-protein signaling 14 |
2269 |
0.16 |
chr4_89451816_89451967 | 7.70 |
Gm12608 |
predicted gene 12608 |
7247 |
0.22 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 13.9 | GO:0060435 | bronchiole development(GO:0060435) |
4.2 | 16.8 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
4.0 | 19.8 | GO:1904970 | brush border assembly(GO:1904970) |
3.8 | 15.1 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
2.9 | 8.6 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
2.7 | 8.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
2.5 | 7.6 | GO:0072092 | ureteric bud invasion(GO:0072092) |
2.1 | 2.1 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
2.1 | 4.2 | GO:0072275 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
2.0 | 10.2 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.9 | 5.6 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.9 | 7.5 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.9 | 5.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.6 | 4.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.5 | 7.7 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.4 | 4.3 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.4 | 4.3 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
1.3 | 3.9 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
1.3 | 3.8 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
1.2 | 5.0 | GO:0006742 | NADP catabolic process(GO:0006742) |
1.2 | 3.7 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
1.2 | 3.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.2 | 2.4 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
1.2 | 3.5 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
1.2 | 1.2 | GO:0010159 | specification of organ position(GO:0010159) |
1.2 | 3.5 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
1.1 | 4.6 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
1.1 | 3.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.1 | 4.4 | GO:0001880 | Mullerian duct regression(GO:0001880) |
1.1 | 4.4 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
1.0 | 3.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.0 | 5.0 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
1.0 | 9.8 | GO:0043589 | skin morphogenesis(GO:0043589) |
1.0 | 2.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.0 | 3.9 | GO:0002159 | desmosome assembly(GO:0002159) |
1.0 | 2.9 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
1.0 | 2.9 | GO:0007525 | somatic muscle development(GO:0007525) |
0.9 | 3.8 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.9 | 1.8 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.9 | 3.6 | GO:0072179 | nephric duct formation(GO:0072179) |
0.9 | 15.4 | GO:0060065 | uterus development(GO:0060065) |
0.9 | 7.9 | GO:0070269 | pyroptosis(GO:0070269) |
0.9 | 6.9 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.9 | 2.6 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.8 | 4.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.8 | 3.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.8 | 3.3 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.8 | 1.6 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.8 | 3.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.8 | 5.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.8 | 4.5 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.8 | 2.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.8 | 2.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.7 | 3.7 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.7 | 3.0 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.7 | 4.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.7 | 2.8 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.7 | 5.0 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.7 | 2.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.7 | 2.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.7 | 2.1 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.7 | 2.1 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.7 | 2.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.7 | 6.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.7 | 1.4 | GO:0035799 | ureter maturation(GO:0035799) |
0.7 | 2.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.7 | 2.0 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.6 | 4.5 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
0.6 | 1.3 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.6 | 1.3 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.6 | 2.5 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.6 | 1.2 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.6 | 4.2 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.6 | 3.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.6 | 1.8 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.6 | 1.8 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.6 | 0.6 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.6 | 3.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.6 | 1.1 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.6 | 2.3 | GO:0061525 | hindgut development(GO:0061525) |
0.6 | 1.7 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.6 | 2.8 | GO:0019695 | choline metabolic process(GO:0019695) |
0.6 | 2.8 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.5 | 1.1 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.5 | 2.7 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.5 | 1.6 | GO:0006868 | glutamine transport(GO:0006868) |
0.5 | 1.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.5 | 2.6 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.5 | 2.1 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.5 | 2.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.5 | 4.6 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.5 | 9.2 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.5 | 1.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.5 | 2.5 | GO:0060023 | soft palate development(GO:0060023) |
0.5 | 7.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.5 | 2.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.5 | 1.5 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.5 | 2.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.5 | 1.0 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.5 | 7.4 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.5 | 1.5 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.5 | 1.9 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.5 | 48.8 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.5 | 7.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.5 | 0.9 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.5 | 1.4 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.5 | 0.9 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.5 | 3.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.5 | 1.4 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.5 | 2.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.5 | 1.8 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.5 | 3.6 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.5 | 0.9 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.4 | 1.3 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.4 | 1.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.4 | 1.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.4 | 1.3 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.4 | 1.8 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.4 | 1.3 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.4 | 2.1 | GO:0090009 | primitive streak formation(GO:0090009) |
0.4 | 2.5 | GO:0060539 | diaphragm development(GO:0060539) |
0.4 | 4.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 | 0.8 | GO:0051182 | coenzyme transport(GO:0051182) |
0.4 | 1.6 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.4 | 2.8 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.4 | 0.8 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.4 | 6.0 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.4 | 1.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.4 | 0.8 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.4 | 1.6 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.4 | 0.8 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.4 | 1.6 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.4 | 0.8 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.4 | 1.2 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.4 | 0.8 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.4 | 0.8 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.4 | 0.4 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.4 | 1.1 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.4 | 1.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.4 | 3.0 | GO:0007097 | nuclear migration(GO:0007097) |
0.4 | 2.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.4 | 1.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.4 | 1.5 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.4 | 1.1 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.4 | 1.5 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.4 | 1.1 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.4 | 3.7 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.4 | 4.7 | GO:0010842 | retina layer formation(GO:0010842) |
0.4 | 1.5 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.4 | 1.1 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.4 | 0.7 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.4 | 1.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.4 | 1.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.4 | 3.9 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.3 | 1.0 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.3 | 0.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.3 | 1.4 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.3 | 1.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.3 | 1.0 | GO:0015888 | thiamine transport(GO:0015888) |
0.3 | 1.3 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.3 | 2.3 | GO:0032328 | alanine transport(GO:0032328) |
0.3 | 1.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.3 | 4.3 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 1.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.3 | 1.0 | GO:0030576 | Cajal body organization(GO:0030576) |
0.3 | 0.3 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.3 | 1.3 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 1.6 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.3 | 0.6 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.3 | 2.3 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.3 | 1.3 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.3 | 1.0 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.3 | 1.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.3 | 1.3 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) |
0.3 | 4.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.3 | 0.9 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.3 | 0.9 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.3 | 0.6 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.3 | 0.3 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.3 | 1.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 0.9 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.3 | 0.9 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.3 | 0.9 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.3 | 1.9 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.3 | 2.2 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.3 | 0.6 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.3 | 1.8 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.3 | 1.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.3 | 0.3 | GO:1901524 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
0.3 | 1.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.3 | 0.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.3 | 4.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 0.9 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.3 | 0.3 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.3 | 1.5 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.3 | 0.6 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.3 | 2.7 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.3 | 1.2 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.3 | 1.5 | GO:0015871 | choline transport(GO:0015871) |
0.3 | 6.8 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.3 | 1.2 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.3 | 2.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.3 | 0.9 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.3 | 2.3 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.3 | 1.5 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.3 | 1.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 1.2 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.3 | 0.6 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.3 | 1.7 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.3 | 0.3 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
0.3 | 0.6 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.3 | 1.1 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.3 | 0.8 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.3 | 1.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.3 | 0.6 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.3 | 1.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.3 | 0.8 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.3 | 0.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.3 | 1.6 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.3 | 0.8 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.3 | 0.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 3.2 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.3 | 1.1 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.3 | 0.3 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.3 | 0.3 | GO:0008050 | female courtship behavior(GO:0008050) |
0.3 | 1.1 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.3 | 0.8 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.3 | 0.3 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.3 | 0.8 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.3 | 0.3 | GO:0032714 | negative regulation of interleukin-13 production(GO:0032696) negative regulation of interleukin-5 production(GO:0032714) |
0.3 | 0.8 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.3 | 1.0 | GO:0001842 | neural fold formation(GO:0001842) |
0.3 | 0.8 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.3 | 1.3 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.3 | 0.5 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.3 | 1.0 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.3 | 0.8 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.3 | 2.6 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.3 | 1.3 | GO:0036035 | osteoclast development(GO:0036035) |
0.3 | 0.5 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.3 | 1.0 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.3 | 0.3 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.3 | 0.8 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.3 | 0.5 | GO:0010182 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.3 | 1.3 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.3 | 1.0 | GO:0050955 | thermoception(GO:0050955) |
0.3 | 0.3 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.3 | 0.8 | GO:0030035 | microspike assembly(GO:0030035) |
0.3 | 3.5 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.3 | 2.8 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
0.3 | 3.5 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.2 | 0.7 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 0.2 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.2 | 1.2 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 1.0 | GO:0032570 | response to progesterone(GO:0032570) |
0.2 | 1.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 3.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 0.7 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.2 | 2.9 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.2 | 0.7 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.2 | 0.7 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
0.2 | 0.7 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.2 | 0.5 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
0.2 | 3.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 1.5 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.2 | 0.5 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 4.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.2 | 0.5 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 1.0 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.2 | 0.7 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 1.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.2 | 2.6 | GO:0019985 | translesion synthesis(GO:0019985) |
0.2 | 0.9 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.2 | 0.9 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.2 | 0.2 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.2 | 2.6 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 0.7 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 1.9 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 0.9 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.2 | 0.7 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.2 | 3.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 0.5 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 0.7 | GO:0036394 | amylase secretion(GO:0036394) |
0.2 | 0.9 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.2 | 0.9 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 | 0.7 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.2 | 0.2 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.2 | 0.9 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.2 | 1.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 1.6 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.2 | 2.7 | GO:0030033 | microvillus assembly(GO:0030033) |
0.2 | 0.7 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.2 | 0.2 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.2 | 0.9 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.2 | 0.4 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.2 | 0.9 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.2 | 0.4 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.2 | 0.2 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.2 | 1.1 | GO:0015791 | polyol transport(GO:0015791) |
0.2 | 1.9 | GO:0070633 | transepithelial transport(GO:0070633) |
0.2 | 0.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.2 | 1.1 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.2 | 0.6 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.2 | 0.8 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.2 | 0.2 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.2 | 0.4 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.2 | 0.4 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 0.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.6 | GO:2000192 | negative regulation of fatty acid transport(GO:2000192) |
0.2 | 1.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.2 | 1.0 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.2 | 0.2 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.2 | 0.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 0.6 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.2 | 0.6 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 0.8 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.2 | 0.2 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 1.6 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.2 | 0.4 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 0.2 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.2 | 0.2 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.2 | 0.6 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.2 | 0.6 | GO:0061511 | centriole elongation(GO:0061511) |
0.2 | 1.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.2 | 0.8 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.2 | 0.4 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.2 | 1.6 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 0.4 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.2 | 0.4 | GO:0001555 | oocyte growth(GO:0001555) |
0.2 | 0.6 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.2 | 0.6 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.2 | 0.2 | GO:0033034 | positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.2 | 1.0 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 1.0 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 1.0 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.2 | 1.9 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.2 | 0.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 0.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.2 | 0.6 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.2 | 0.2 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.2 | 0.8 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 0.4 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.2 | 0.8 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 0.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 0.4 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.2 | 1.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.2 | 1.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 1.1 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) |
0.2 | 0.9 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.2 | 0.7 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 0.7 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.2 | 0.9 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.2 | 0.9 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.2 | 0.7 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.2 | 0.7 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 1.3 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.2 | 7.1 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.2 | 0.7 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.2 | 0.5 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.2 | 0.5 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.2 | 0.5 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.2 | 1.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 0.7 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.2 | 1.9 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 0.4 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 0.5 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.2 | 0.5 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.2 | 0.7 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 0.2 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.2 | 0.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 0.4 | GO:0046689 | response to mercury ion(GO:0046689) |
0.2 | 0.9 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.7 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 0.7 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.2 | 0.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.2 | 1.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 0.5 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.2 | 0.2 | GO:0001705 | ectoderm formation(GO:0001705) |
0.2 | 0.3 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.2 | 0.5 | GO:0030421 | defecation(GO:0030421) |
0.2 | 0.2 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.2 | 0.3 | GO:0002254 | kinin cascade(GO:0002254) |
0.2 | 0.3 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.2 | 0.5 | GO:0060426 | lung vasculature development(GO:0060426) |
0.2 | 0.5 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.2 | 0.7 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 0.3 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.2 | 0.3 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.2 | 0.2 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 2.4 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 0.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 1.5 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.2 | 0.3 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.2 | 0.7 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 0.5 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 0.5 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 0.8 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.2 | 1.0 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.2 | 0.2 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 0.3 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.2 | 0.5 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 0.5 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.2 | 2.5 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.2 | 0.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 1.3 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 0.5 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.2 | 1.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 0.8 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.2 | 0.5 | GO:0098856 | intestinal lipid absorption(GO:0098856) |
0.2 | 0.5 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.2 | 0.8 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 0.8 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.2 | 0.3 | GO:0048557 | embryonic digestive tract morphogenesis(GO:0048557) |
0.2 | 0.7 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 0.7 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.2 | 2.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 0.2 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.2 | 0.8 | GO:0042737 | drug catabolic process(GO:0042737) |
0.2 | 2.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.2 | 0.2 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.2 | 0.5 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 0.5 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 0.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.2 | 3.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 0.2 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.2 | 1.1 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.2 | 0.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.2 | 0.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.6 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.2 | 0.9 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.3 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.2 | 0.5 | GO:0060068 | vagina development(GO:0060068) |
0.2 | 0.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 0.3 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 0.3 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.2 | 0.3 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.2 | 1.7 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 0.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 1.2 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 0.9 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.2 | 0.2 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.2 | 0.5 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 0.3 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.1 | 0.3 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 2.1 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.6 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.3 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.4 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.1 | 0.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 2.8 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.9 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 3.4 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.1 | 1.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.3 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.1 | 0.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.4 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.1 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.1 | 1.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.3 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 0.9 | GO:1902224 | ketone body metabolic process(GO:1902224) |
0.1 | 0.7 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 0.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 1.0 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.3 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.1 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 0.1 | GO:0042161 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.1 | 0.1 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.1 | 0.9 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 1.7 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.1 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.7 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.3 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.1 | 0.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 6.0 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 1.0 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.8 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.4 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.4 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.1 | 1.3 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.4 | GO:0046607 | positive regulation of centrosome duplication(GO:0010825) positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.1 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 0.4 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.3 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.3 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.1 | 0.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 0.3 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 0.4 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.5 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.1 | 2.0 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 0.8 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 1.1 | GO:0070242 | thymocyte apoptotic process(GO:0070242) |
0.1 | 0.5 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.1 | 0.1 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.1 | 0.5 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 1.6 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 3.2 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.1 | 0.4 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.1 | 0.1 | GO:0098739 | import across plasma membrane(GO:0098739) |
0.1 | 1.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.4 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.5 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.1 | 0.1 | GO:0019740 | regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) |
0.1 | 0.1 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.1 | 0.3 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.1 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.3 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 1.3 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.6 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 1.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.6 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.8 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.3 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.1 | 1.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.9 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.2 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 0.2 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 0.7 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.5 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.5 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.1 | 0.2 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.1 | 0.2 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.2 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.1 | 0.1 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.1 | 12.1 | GO:0071241 | cellular response to inorganic substance(GO:0071241) |
0.1 | 0.4 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 1.2 | GO:0042312 | regulation of vasodilation(GO:0042312) |
0.1 | 0.7 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.1 | 0.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.1 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.1 | 0.7 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.4 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.2 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.1 | 0.4 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.4 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.2 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.1 | 0.2 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.1 | 1.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 1.4 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 0.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.5 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.1 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.7 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.8 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.6 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.2 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.1 | 0.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.6 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.6 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.3 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.2 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 0.9 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.1 | 0.1 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.1 | 0.1 | GO:0072240 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.1 | 1.2 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.3 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.1 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 0.3 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.1 | 0.7 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.2 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
0.1 | 8.3 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.1 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.5 | GO:0021764 | amygdala development(GO:0021764) |
0.1 | 2.4 | GO:0010324 | membrane invagination(GO:0010324) |
0.1 | 0.4 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.1 | 0.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.5 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.1 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.1 | 1.0 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 0.2 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.3 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 1.8 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.1 | 0.6 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) terpenoid biosynthetic process(GO:0016114) |
0.1 | 0.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.3 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.2 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.1 | 1.2 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.1 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 1.0 | GO:0050820 | positive regulation of coagulation(GO:0050820) |
0.1 | 0.3 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.1 | 0.2 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.1 | 1.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.3 | GO:0002760 | positive regulation of antimicrobial humoral response(GO:0002760) |
0.1 | 0.4 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.3 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.1 | 0.8 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.1 | 0.1 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.1 | 0.2 | GO:0003094 | glomerular filtration(GO:0003094) |
0.1 | 1.6 | GO:0035094 | response to nicotine(GO:0035094) |
0.1 | 1.2 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.1 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.1 | 0.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.5 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 6.7 | GO:0048705 | skeletal system morphogenesis(GO:0048705) |
0.1 | 0.1 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.1 | 0.5 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.1 | 0.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 1.3 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.1 | 1.3 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 0.6 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 0.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.1 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 0.9 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.5 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.2 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.1 | 0.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.1 | 0.2 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.2 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.6 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.1 | 0.4 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.1 | 0.5 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.3 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 0.4 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 1.2 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.1 | 0.6 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 0.2 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.6 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.1 | GO:0072108 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
0.1 | 0.6 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.1 | 0.3 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 0.3 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.1 | 0.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.1 | GO:0032898 | neurotrophin production(GO:0032898) |
0.1 | 0.4 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.3 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.3 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.1 | 0.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.2 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.1 | 0.4 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.3 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.1 | 0.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.1 | 0.9 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.2 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.1 | 1.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.3 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.6 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 1.0 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.3 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.1 | 0.9 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.3 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.1 | 0.6 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.7 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.1 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 1.9 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.4 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 1.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.2 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.1 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.3 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.3 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 5.9 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
0.1 | 0.4 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.2 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.2 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.2 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 0.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.1 | GO:0014745 | negative regulation of muscle adaptation(GO:0014745) |
0.1 | 0.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.3 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.6 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.1 | 0.3 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.1 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.4 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.1 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 0.2 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.2 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 1.5 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.1 | GO:0010513 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) regulation of phosphatidylinositol biosynthetic process(GO:0010511) positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.1 | 0.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 0.6 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.1 | 0.3 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.2 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 0.4 | GO:0030539 | male genitalia development(GO:0030539) |
0.1 | 0.1 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.5 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.1 | 0.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.5 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 1.1 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.4 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.1 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.4 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.2 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 0.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 1.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.1 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
0.1 | 0.3 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.1 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.1 | 0.4 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 1.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.6 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.5 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 1.0 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 0.9 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.1 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.1 | 0.3 | GO:1905038 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.1 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 0.4 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 0.5 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.6 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.1 | GO:0036166 | phenotypic switching(GO:0036166) |
0.1 | 0.1 | GO:0060571 | morphogenesis of an epithelial fold(GO:0060571) |
0.1 | 1.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.2 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 1.1 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 0.8 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.1 | 0.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 1.1 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.2 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.7 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.3 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 0.2 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.7 | GO:0032402 | establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) |
0.1 | 0.1 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.1 | 0.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 1.0 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 0.7 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.1 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.1 | 0.6 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.9 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.3 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 0.3 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 1.2 | GO:0009408 | response to heat(GO:0009408) |
0.1 | 0.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.1 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
0.1 | 0.1 | GO:1904177 | positive regulation of actin filament-based movement(GO:1903116) regulation of adipose tissue development(GO:1904177) positive regulation of adipose tissue development(GO:1904179) |
0.1 | 0.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.1 | 0.5 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.3 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.1 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 1.6 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.1 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.1 | 1.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.1 | 0.3 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
0.1 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.1 | 0.8 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.1 | 0.3 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.1 | 0.2 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.1 | 0.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.1 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
0.1 | 0.1 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.1 | 1.4 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.1 | 0.1 | GO:0071351 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.1 | 0.1 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 0.1 | GO:0061081 | positive regulation of macrophage cytokine production(GO:0060907) positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.1 | 0.4 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.4 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.1 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.1 | 0.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.2 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.1 | 0.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.1 | 0.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.1 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
0.1 | 0.5 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.6 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.1 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.1 | 0.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 0.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.1 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.3 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 0.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.3 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.2 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.5 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.2 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.1 | 0.2 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 0.1 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.1 | 0.2 | GO:0051256 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.1 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.1 | 0.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.1 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 0.1 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.1 | GO:0045837 | negative regulation of membrane potential(GO:0045837) |
0.1 | 1.6 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 1.4 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.2 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.1 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
0.1 | 0.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.1 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.1 | 0.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 0.3 | GO:0010543 | regulation of platelet activation(GO:0010543) |
0.1 | 1.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.4 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.1 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.1 | 0.1 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.1 | 0.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.1 | GO:0035087 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.1 | 0.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.2 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 0.1 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.3 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.1 | GO:0016553 | adenosine to inosine editing(GO:0006382) base conversion or substitution editing(GO:0016553) |
0.1 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 0.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.3 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.7 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.1 | 0.1 | GO:0030070 | insulin processing(GO:0030070) |
0.0 | 0.5 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.0 | 0.0 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.0 | GO:0043305 | negative regulation of mast cell activation involved in immune response(GO:0033007) negative regulation of mast cell degranulation(GO:0043305) |
0.0 | 0.0 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.0 | 0.6 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.4 | GO:0043486 | histone exchange(GO:0043486) |
0.0 | 0.2 | GO:0042772 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.0 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.8 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 2.2 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.0 | 0.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.0 | 1.4 | GO:0001889 | liver development(GO:0001889) |
0.0 | 0.0 | GO:0072017 | distal tubule development(GO:0072017) |
0.0 | 0.6 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.8 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.1 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.0 | 0.2 | GO:0055021 | regulation of cardiac muscle tissue growth(GO:0055021) |
0.0 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.1 | GO:1904396 | regulation of neuromuscular junction development(GO:1904396) |
0.0 | 0.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.2 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 1.2 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.4 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.3 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.0 | 1.3 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.0 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.0 | 0.0 | GO:2000142 | regulation of DNA-templated transcription, initiation(GO:2000142) |
0.0 | 0.0 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.0 | 0.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.4 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.4 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.0 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.1 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.1 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.0 | 0.1 | GO:0072044 | collecting duct development(GO:0072044) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.5 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.0 | 0.3 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.5 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.0 | 0.0 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.0 | 0.0 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.0 | 0.0 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.0 | 0.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.0 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.0 | 0.2 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.0 | GO:0002158 | osteoclast proliferation(GO:0002158) regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.0 | 0.0 | GO:0032612 | interleukin-1 production(GO:0032612) |
0.0 | 0.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.3 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.0 | 0.2 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.1 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.0 | 0.2 | GO:0045072 | regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.0 | 0.0 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.0 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.0 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) |
0.0 | 0.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.0 | 0.0 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.0 | 0.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.2 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.1 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.0 | 0.1 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.0 | 0.9 | GO:0071456 | cellular response to hypoxia(GO:0071456) |
0.0 | 0.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.5 | GO:0090278 | negative regulation of peptide hormone secretion(GO:0090278) |
0.0 | 1.6 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.0 | 0.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.7 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.3 | GO:0042755 | eating behavior(GO:0042755) |
0.0 | 0.3 | GO:0045058 | T cell selection(GO:0045058) |
0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.5 | GO:2001259 | positive regulation of cation channel activity(GO:2001259) |
0.0 | 0.0 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.0 | 0.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.1 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.0 | 0.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.1 | GO:0034114 | regulation of heterotypic cell-cell adhesion(GO:0034114) |
0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.5 | GO:0035690 | cellular response to drug(GO:0035690) |
0.0 | 0.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.0 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.0 | 0.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.0 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.0 | 0.9 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.0 | GO:0051938 | L-glutamate import(GO:0051938) L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.0 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.0 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.1 | GO:0044766 | multi-organism transport(GO:0044766) multi-organism localization(GO:1902579) |
0.0 | 0.1 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.0 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.1 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.0 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.0 | GO:0097106 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) |
0.0 | 0.0 | GO:0001840 | neural plate development(GO:0001840) |
0.0 | 0.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.1 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.0 | 0.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.0 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.2 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.0 | 0.0 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.0 | 0.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.1 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.0 | GO:0032799 | low-density lipoprotein receptor particle metabolic process(GO:0032799) |
0.0 | 0.0 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.0 | 0.1 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.0 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 | 0.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.3 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.0 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.0 | GO:0045851 | pH reduction(GO:0045851) |
0.0 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.0 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.0 | 0.0 | GO:0034311 | diol metabolic process(GO:0034311) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.0 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.1 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
0.0 | 0.0 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.0 | 0.5 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.0 | 0.2 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.0 | 0.7 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 0.0 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.0 | 0.3 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.2 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.0 | 0.0 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.0 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.0 | 0.1 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.2 | GO:0090307 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.0 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.0 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.0 | GO:0045683 | negative regulation of epidermis development(GO:0045683) |
0.0 | 0.1 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 1.0 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0090427 | activation of meiosis(GO:0090427) |
0.0 | 0.3 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.0 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.2 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.0 | 0.0 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.1 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.0 | 0.1 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.0 | 0.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.1 | GO:0071711 | basement membrane organization(GO:0071711) |
0.0 | 0.0 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.0 | 0.0 | GO:0006549 | isoleucine metabolic process(GO:0006549) leucine metabolic process(GO:0006551) |
0.0 | 0.1 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.0 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.1 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.0 | 1.5 | GO:0030509 | BMP signaling pathway(GO:0030509) |
0.0 | 0.0 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.0 | 0.3 | GO:0034614 | cellular response to reactive oxygen species(GO:0034614) |
0.0 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.0 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.0 | 0.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.0 | 0.1 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.0 | 0.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.2 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.0 | 0.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.0 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.0 | 0.0 | GO:1901626 | regulation of postsynaptic membrane organization(GO:1901626) |
0.0 | 0.0 | GO:1990748 | detoxification(GO:0098754) cellular detoxification(GO:1990748) |
0.0 | 0.1 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.1 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.0 | 0.0 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.0 | 0.0 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.2 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.2 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.0 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.1 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.0 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.0 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.0 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) |
0.0 | 0.1 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.2 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.0 | 0.0 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.1 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 | 0.1 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.0 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.0 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.0 | 0.7 | GO:0006956 | complement activation(GO:0006956) |
0.0 | 0.0 | GO:0010288 | response to iron(II) ion(GO:0010040) response to lead ion(GO:0010288) |
0.0 | 0.0 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.0 | 0.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.1 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.0 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.0 | 0.0 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.0 | 0.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.0 | GO:0015840 | urea transport(GO:0015840) |
0.0 | 0.0 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.0 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.1 | GO:0030104 | water homeostasis(GO:0030104) |
0.0 | 0.0 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.0 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.1 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.0 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.1 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.0 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.3 | GO:0044259 | multicellular organismal macromolecule metabolic process(GO:0044259) |
0.0 | 0.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.2 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.0 | 0.1 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.0 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.0 | 0.0 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.0 | 0.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.0 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.0 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.0 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.2 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.0 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.1 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.0 | 0.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.0 | 0.1 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.0 | 0.0 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.0 | 0.1 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.0 | 0.0 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.2 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.0 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.0 | 0.2 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.0 | 0.0 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.0 | 0.0 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 0.1 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.0 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.0 | 0.0 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.0 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.0 | 0.0 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.0 | 0.0 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.0 | 0.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.0 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.0 | GO:0040031 | snRNA modification(GO:0040031) |
0.0 | 0.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.0 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.0 | 0.1 | GO:0034340 | response to type I interferon(GO:0034340) |
0.0 | 0.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.0 | GO:0044117 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.0 | 1.5 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.0 | GO:0031269 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) |
0.0 | 0.0 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.0 | GO:1902074 | response to salt(GO:1902074) |
0.0 | 1.7 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.0 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.0 | 0.0 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.0 | 0.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 0.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.0 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.0 | 0.1 | GO:0006560 | proline metabolic process(GO:0006560) |
0.0 | 0.1 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.0 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.0 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.0 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.1 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.0 | 0.0 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.0 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.0 | 0.0 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.0 | 0.0 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.0 | 0.0 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.0 | 0.0 | GO:0032925 | regulation of activin receptor signaling pathway(GO:0032925) |
0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.0 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.3 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.0 | 0.0 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.0 | 0.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.0 | GO:0044774 | mitotic DNA integrity checkpoint(GO:0044774) |
0.0 | 0.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.5 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.0 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.0 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.0 | 0.0 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.0 | 0.0 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.0 | 0.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.0 | GO:0043586 | tongue development(GO:0043586) |
0.0 | 0.0 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.0 | 0.0 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.0 | 0.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.0 | 0.1 | GO:0070265 | necrotic cell death(GO:0070265) |
0.0 | 0.0 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.0 | GO:0071514 | genetic imprinting(GO:0071514) |
0.0 | 0.0 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.0 | 0.0 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.0 | 0.0 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.1 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.0 | GO:0060416 | response to growth hormone(GO:0060416) |
0.0 | 0.0 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.0 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.0 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.0 | GO:1903299 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) |
0.0 | 0.0 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.0 | 0.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 14.7 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
2.0 | 7.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.4 | 4.3 | GO:1990635 | proximal dendrite(GO:1990635) |
1.2 | 3.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.8 | 3.3 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.8 | 7.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.7 | 2.2 | GO:0005914 | spot adherens junction(GO:0005914) |
0.7 | 3.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.7 | 2.8 | GO:0072487 | MSL complex(GO:0072487) |
0.6 | 7.5 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.6 | 1.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.6 | 8.0 | GO:0031527 | filopodium membrane(GO:0031527) |
0.6 | 2.8 | GO:0033503 | HULC complex(GO:0033503) |
0.5 | 2.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 5.5 | GO:0016600 | flotillin complex(GO:0016600) |
0.5 | 3.7 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.4 | 1.3 | GO:0097513 | myosin II filament(GO:0097513) |
0.4 | 0.4 | GO:0016460 | myosin II complex(GO:0016460) |
0.4 | 1.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.4 | 1.2 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.4 | 1.6 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.4 | 17.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.4 | 1.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.4 | 2.2 | GO:0016589 | NURF complex(GO:0016589) |
0.4 | 2.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.3 | 2.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 1.7 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.3 | 1.7 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.3 | 1.0 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.3 | 3.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 2.5 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.3 | 2.8 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 8.7 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 0.9 | GO:1990462 | omegasome(GO:1990462) |
0.3 | 1.8 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.3 | 2.0 | GO:0071546 | pi-body(GO:0071546) |
0.3 | 1.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.3 | 0.5 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.3 | 2.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 2.7 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 4.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 12.9 | GO:0032587 | ruffle membrane(GO:0032587) |
0.3 | 1.6 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.3 | 2.8 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 2.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 1.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 2.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 0.9 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 4.1 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 5.2 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.2 | 0.7 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 1.3 | GO:0002177 | manchette(GO:0002177) |
0.2 | 2.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 1.5 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 5.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 0.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 1.3 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 0.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.2 | 2.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.2 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.2 | 1.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 1.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 0.8 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 0.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 0.6 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 1.5 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.2 | 0.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 0.5 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 2.0 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 0.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 0.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.4 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 3.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 6.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 0.7 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 1.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 0.5 | GO:0000811 | GINS complex(GO:0000811) |
0.2 | 0.2 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.2 | 0.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.2 | 1.1 | GO:0005688 | U6 snRNP(GO:0005688) |
0.2 | 1.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 0.5 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 1.9 | GO:1904949 | ATPase complex(GO:1904949) |
0.2 | 2.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 1.6 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 0.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 0.9 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 4.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 1.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.6 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 0.4 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 1.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.7 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 2.3 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.9 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.7 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 1.0 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.7 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.4 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 1.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 14.5 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.6 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.8 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 3.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 1.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 1.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.7 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 0.5 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 2.5 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 1.3 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 5.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 2.8 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 10.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.6 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.2 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 1.0 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 2.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 2.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 1.8 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.1 | 1.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.7 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 1.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 2.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 1.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 6.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 6.7 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 0.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.8 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 1.5 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.4 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.4 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 1.2 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 1.8 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.1 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.1 | 0.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 4.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.4 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 1.1 | GO:0031430 | M band(GO:0031430) |
0.1 | 1.8 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 1.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 1.3 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 0.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.1 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 1.1 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.2 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 2.7 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.3 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.5 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 1.4 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 1.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.8 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 2.9 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.4 | GO:0000801 | central element(GO:0000801) |
0.1 | 6.8 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 1.2 | GO:0031672 | A band(GO:0031672) |
0.1 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 1.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.6 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.6 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.9 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.3 | GO:0045252 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.9 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.4 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 1.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 0.3 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.5 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 0.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 2.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.2 | GO:0002141 | stereocilia ankle link(GO:0002141) |
0.1 | 0.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 2.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 15.4 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.4 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.1 | 36.3 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 0.4 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.2 | GO:0097433 | dense body(GO:0097433) |
0.1 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.7 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.5 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.1 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.1 | 0.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 1.0 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 2.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 14.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 3.1 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 1.9 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 0.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 0.0 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.0 | 0.6 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.2 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 4.3 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.0 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 2.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.3 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.4 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 0.9 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 4.8 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.5 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 5.6 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 4.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 2.4 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 3.7 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.6 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.5 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.0 | 0.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.1 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 0.0 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.2 | GO:0036452 | ESCRT complex(GO:0036452) |
0.0 | 0.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.0 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.0 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 2.3 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.0 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.3 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 1.1 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.2 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 1.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.5 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.0 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.2 | GO:0033202 | DNA helicase complex(GO:0033202) INO80-type complex(GO:0097346) |
0.0 | 0.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.4 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.1 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.1 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 0.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.0 | 0.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.1 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.3 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.0 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.0 | 17.8 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.3 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.3 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.1 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.0 | GO:0030662 | coated vesicle membrane(GO:0030662) |
0.0 | 0.0 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.1 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.0 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.0 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 2.0 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.0 | 0.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.0 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.0 | GO:0044420 | extracellular matrix component(GO:0044420) |
0.0 | 0.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 40.6 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.0 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.0 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.0 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.7 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.3 | 6.9 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
2.0 | 5.9 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.9 | 5.7 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.6 | 4.7 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
1.3 | 3.9 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
1.3 | 3.8 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
1.2 | 3.5 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
1.2 | 8.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
1.1 | 3.4 | GO:0005119 | smoothened binding(GO:0005119) |
1.0 | 4.9 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
1.0 | 4.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.9 | 7.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.8 | 2.4 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.8 | 3.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.8 | 9.5 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.8 | 2.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.8 | 3.9 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.8 | 0.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.7 | 5.1 | GO:0018647 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.7 | 1.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.7 | 11.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.7 | 2.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.7 | 2.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.7 | 8.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.7 | 2.6 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.6 | 6.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.6 | 5.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.6 | 0.6 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.6 | 2.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.6 | 2.4 | GO:0009374 | biotin binding(GO:0009374) |
0.6 | 13.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.6 | 0.6 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.5 | 2.0 | GO:0042731 | PH domain binding(GO:0042731) |
0.5 | 1.5 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.5 | 1.5 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.5 | 1.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.5 | 1.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.5 | 1.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.5 | 2.3 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.5 | 1.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.4 | 2.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.4 | 2.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.4 | 1.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 12.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.4 | 3.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.4 | 3.5 | GO:0042557 | cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.4 | 1.7 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.4 | 1.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.4 | 1.2 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.4 | 1.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.4 | 1.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.4 | 1.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.4 | 1.6 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.4 | 1.5 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.4 | 5.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.4 | 1.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.4 | 1.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.4 | 1.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.4 | 1.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.4 | 1.1 | GO:0015265 | urea channel activity(GO:0015265) |
0.4 | 3.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.4 | 2.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.4 | 1.1 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.4 | 1.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.3 | 1.4 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.3 | 1.0 | GO:0030172 | troponin C binding(GO:0030172) |
0.3 | 0.7 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.3 | 1.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.3 | 7.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 1.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.3 | 1.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.3 | 0.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.3 | 3.3 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.3 | 2.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 1.0 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.3 | 1.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 2.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 3.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 1.0 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.3 | 3.9 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 2.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 2.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 2.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 1.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 4.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.3 | 1.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.3 | 3.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 0.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 1.8 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 1.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.3 | 1.2 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.3 | 0.9 | GO:0008142 | oxysterol binding(GO:0008142) |
0.3 | 0.9 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.3 | 1.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 0.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.3 | 1.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 3.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 2.0 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.3 | 1.5 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.3 | 0.9 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.3 | 4.0 | GO:0022840 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.3 | 1.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.3 | 0.9 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.3 | 0.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 6.7 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.3 | 0.3 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.3 | 0.6 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.3 | 1.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 1.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 1.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 5.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 2.1 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 0.8 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.3 | 0.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.3 | 0.8 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.3 | 0.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 3.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.3 | 1.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 4.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 0.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.2 | 0.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 5.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 2.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 1.2 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 1.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 1.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 0.7 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 16.1 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.2 | 1.4 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 2.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.2 | 0.7 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 0.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 0.9 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 0.9 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.2 | 1.4 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 5.7 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 0.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 3.9 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 1.4 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 4.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 0.9 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 0.4 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.2 | 1.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 0.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 3.6 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 5.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 0.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.2 | 1.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 0.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 7.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 1.9 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 1.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 1.9 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.2 | 1.6 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.2 | 1.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 2.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 3.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 0.6 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.2 | 0.6 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.2 | 3.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.2 | 2.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 0.6 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.2 | 2.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.8 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 3.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 0.2 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.2 | 1.0 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.2 | 2.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 1.5 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 0.6 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.2 | 0.9 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 1.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.7 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 0.5 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 0.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 6.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 0.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 1.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 1.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 0.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 0.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 0.8 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 0.3 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.2 | 1.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 2.3 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 0.8 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 5.7 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.5 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 0.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 0.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 2.6 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.2 | 0.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 0.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 0.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 0.5 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 6.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 0.3 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 0.6 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 1.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.4 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 1.0 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 6.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 1.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.3 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.4 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 1.3 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 0.7 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 1.3 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.7 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.7 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 1.0 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 9.2 | GO:0019838 | growth factor binding(GO:0019838) |
0.1 | 1.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 1.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 1.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 1.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.8 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 7.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 1.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 2.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.4 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 1.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.4 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 1.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.4 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 3.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 1.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.6 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 0.1 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.1 | 0.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.4 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.6 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 2.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.4 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 1.7 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.7 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 0.6 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.8 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.1 | 0.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 2.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.1 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.1 | 1.0 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 1.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 27.9 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.4 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 1.0 | GO:0052685 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 1.0 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.3 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 0.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.3 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.6 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.4 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.4 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 0.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 0.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.4 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.1 | 0.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 1.1 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
0.1 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 0.9 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.5 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 1.6 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.1 | 1.6 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 3.7 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 0.1 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 5.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 1.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 3.8 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 2.9 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.1 | 2.4 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.4 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.7 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 1.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.3 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 2.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.1 | 0.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.5 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 2.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 1.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.5 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.6 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 1.7 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 3.7 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 45.4 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 0.4 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.9 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.6 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.1 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.2 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 2.3 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 1.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.1 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.1 | 0.1 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 1.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 1.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 2.9 | GO:0044823 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.4 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 0.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 2.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 3.2 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.1 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.6 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 1.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.3 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 0.1 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.6 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.1 | 0.8 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 1.1 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 1.6 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 3.0 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 1.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 1.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.5 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 1.1 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 2.2 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.1 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.1 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.1 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 1.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.6 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 1.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 1.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 5.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.4 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.3 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.7 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 3.9 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.5 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 0.1 | GO:0019198 | transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 0.3 | GO:0010851 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 2.6 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 3.7 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.7 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.4 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.5 | GO:0030546 | receptor activator activity(GO:0030546) |
0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 2.7 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 1.8 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 1.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.7 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.7 | GO:0050661 | NADP binding(GO:0050661) |
0.0 | 0.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.8 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.5 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 1.7 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.3 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.0 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.6 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.1 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.0 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 0.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.4 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 1.0 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.0 | 0.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.0 | 0.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.0 | 0.0 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 2.1 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.1 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.0 | 0.5 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 0.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 2.6 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.2 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.0 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 1.4 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.0 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.0 | 0.4 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.0 | 0.0 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.2 | GO:0047419 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.0 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.0 | 0.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.2 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.1 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.0 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.0 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.7 | GO:0070851 | growth factor receptor binding(GO:0070851) |
0.0 | 0.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.0 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.0 | 0.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.0 | 0.0 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.0 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.0 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.1 | GO:0034951 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.0 | 0.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.0 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.0 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.0 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 0.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.0 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.1 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.0 | 0.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.0 | 0.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.8 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.0 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.0 | 0.0 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.0 | GO:2001070 | starch binding(GO:2001070) |
0.0 | 0.0 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.0 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.0 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.0 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 2.0 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.0 | 0.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.0 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.0 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.0 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.0 | 0.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.0 | GO:0035240 | dopamine binding(GO:0035240) |
0.0 | 0.0 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.0 | 0.0 | GO:0036122 | BMP binding(GO:0036122) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 12.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.6 | 1.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.6 | 16.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 4.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.4 | 7.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 4.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 9.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.4 | 5.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.4 | 11.0 | PID ARF6 PATHWAY | Arf6 signaling events |
0.4 | 5.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.4 | 6.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 13.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.4 | 8.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.3 | 4.0 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 4.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 6.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 0.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 4.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 6.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 10.3 | PID BMP PATHWAY | BMP receptor signaling |
0.3 | 6.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.3 | 6.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 10.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.3 | 1.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 3.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 0.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 2.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 2.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 6.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 0.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 3.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 2.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 5.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 3.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 3.7 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 6.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 1.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 2.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.9 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 2.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 4.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 3.1 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 5.9 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 2.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.7 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 3.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 8.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 1.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 1.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 0.5 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 1.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 1.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 3.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 2.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.9 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 12.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 9.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 5.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 4.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 1.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.4 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.0 | 0.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 9.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.8 | 3.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.8 | 1.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.6 | 5.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.6 | 10.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.5 | 5.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 13.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.4 | 0.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.4 | 7.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.4 | 3.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 3.4 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.3 | 2.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 1.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 3.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 5.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 1.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.3 | 0.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 2.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 6.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 2.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.3 | 2.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 3.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 4.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 1.0 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.2 | 6.5 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.2 | 0.5 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.2 | 1.8 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 3.4 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.2 | 1.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 0.4 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.2 | 3.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.2 | 2.6 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 3.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 6.0 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 4.1 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.2 | 2.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 7.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 1.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 3.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 0.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 5.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 5.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 3.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 4.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 2.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 1.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 2.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 2.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 0.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 9.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 5.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 2.2 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.2 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 1.8 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 2.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 2.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 5.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 2.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 6.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 2.6 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 1.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 6.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 0.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 1.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 2.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.4 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 0.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 2.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 1.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 1.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 2.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 0.8 | REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT | Genes involved in SLC-mediated transmembrane transport |
0.1 | 2.0 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 1.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 2.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 2.6 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 0.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 1.6 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 1.1 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 2.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 3.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 1.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 3.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 0.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 2.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.9 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.5 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 0.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.9 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.1 | 0.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 0.3 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 0.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 0.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 0.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 0.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 3.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 2.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 1.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 1.5 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 1.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.4 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 1.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 1.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.4 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.0 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.1 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.6 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.2 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.2 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 5.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 1.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.2 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 1.1 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.2 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.0 | 0.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.4 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.0 | 0.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.5 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.6 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.3 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.0 | 0.1 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.0 | 0.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.0 | REACTOME S PHASE | Genes involved in S Phase |
0.0 | 0.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.0 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.0 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.0 | 1.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |